RYZB insider filings
RayzeBio, Inc. — 23 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-02-28. Screen RYZB transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for RYZB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — RayzeBio, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-28 | 4 | VIKING GLOBAL INVESTORS LP — 10% owner Viking Global Opportunities Parent GP LLC — 10% owner Viking Global Opportunities Drawdown GP LLC — 10% owner Viking Global Opportunities Drawdown Portfolio GP LLC — 10% owner Viking Global Opportunities Drawdown (Aggregator) LP — 10% owner HALVORSEN OLE ANDREAS — 10% owner Ott David C. — 10% owner Shabet Rose Sharon — 10% owner | Other (J): 4,899,144 · Other (J): 1,743,556 | EDGAR |
| 2024-02-28 | 4 | VIKING GLOBAL INVESTORS LP — 10% owner Viking Global Opportunities Parent GP LLC — 10% owner Viking Global Opportunities GP LLC — 10% owner Viking Global Opportunities Portfolio GP LLC — 10% owner Viking Global Opportunities Illiquid Investments Sub-Master LP — 10% owner HALVORSEN OLE ANDREAS — 10% owner Ott David C. — 10% owner Shabet Rose Sharon — 10% owner | Other (J): 4,899,144 · Other (J): 1,743,556 | EDGAR |
| 2024-02-27 | 4 | Moran Susan — CHIEF MEDICAL OFFICER | Disposition to issuer (D): 323,455 @ $62.50 · Disposition to issuer (D): 60,757 (derivative) · Disposition to issuer (D): 77,805 (derivative) · Disposition to issuer (D): 194,514 (derivative) · Disposition to issuer (D): 164,000 (derivative) | EDGAR |
| 2024-02-27 | 4 | Kush Arvind — CHIEF FINANCIAL OFFICER | Disposition to issuer (D): 78,433 @ $62.50 · Disposition to issuer (D): 301,745 (derivative) · Disposition to issuer (D): 149,777 (derivative) · Disposition to issuer (D): 164,000 (derivative) | EDGAR |
| 2024-02-27 | 4 | Oliger Christy J. — Director | Disposition to issuer (D): 114,579 (derivative) | EDGAR |
| 2024-02-27 | 4 | Van Hauwermeiren Timothy — Director | Disposition to issuer (D): 48,628 (derivative) | EDGAR |
| 2024-02-27 | 4 | Larson Yi — Director | Disposition to issuer (D): 59,399 (derivative) · Disposition to issuer (D): 14,332 (derivative) · Disposition to issuer (D): 40,848 (derivative) | EDGAR |
| 2024-02-27 | 4 | Katabi Maha — Director | Disposition to issuer (D): 1,209,764 @ $62.50 · Disposition to issuer (D): 1,209,764 @ $62.50 · Disposition to issuer (D): 18,235 (derivative) | EDGAR |
| 2024-02-27 | 4 | You Angie — Director | Disposition to issuer (D): 73,731 (derivative) · Disposition to issuer (D): 40,848 (derivative) | EDGAR |
| 2024-02-27 | 4 | SONG KENNETH — PRESIDENT AND CHIEF EXECUTIVE, Director | Disposition to issuer (D): 1,622,968 @ $62.50 · Disposition to issuer (D): 758,607 (derivative) · Disposition to issuer (D): 114,763 (derivative) · Disposition to issuer (D): 480,000 (derivative) | EDGAR |
| 2024-02-27 | 4 | Heyman Richard A. — Director | Disposition to issuer (D): 367,446 @ $62.50 | EDGAR |
| 2024-02-27 | 4 | TAGLIAFERRI MARY — Director | Disposition to issuer (D): 73,731 (derivative) · Disposition to issuer (D): 40,848 (derivative) | EDGAR |
| 2024-02-06 | 4 | Moran Susan — CHIEF MEDICAL OFFICER | Option exercise (M): 30,875 @ $3.24 · Option exercise (M): 30,875 (derivative) @ $0 | EDGAR |
| 2023-11-17 | 4 | Kush Arvind — Chief Financial Officer | Grant/award (A): 164,000 (derivative) @ $0 | EDGAR |
| 2023-11-17 | 4 | Moran Susan — Chief Medical Officer | Grant/award (A): 164,000 (derivative) @ $0 | EDGAR |
| 2023-11-17 | 4 | Katabi Maha — Director | Grant/award (A): 18,235 (derivative) @ $0 | EDGAR |
| 2023-11-17 | 4 | SONG KENNETH — President and Chief Executive, Director | Grant/award (A): 480,000 (derivative) @ $0 | EDGAR |
| 2023-09-21 | 4 | Katabi Maha — Director | Conversion (C): 973,653 · Conversion (C): 973,653 · Purchase (P): 236,111 @ $18 · Purchase (P): 236,111 @ $18 · Conversion (C): 973,653 (derivative) · Conversion (C): 973,653 (derivative) | EDGAR |
| 2023-09-21 | 4 | Redmile Group, LLC — 10% owner Green Jeremy — 10% owner Redmile Biopharma Investments II, L.P. — 10% owner | Conversion (C): 864,509 · Conversion (C): 494,687 · Conversion (C): 498,510 · Conversion (C): 864,509 (derivative) @ $0 · Conversion (C): 432,254 (derivative) @ $0 · Conversion (C): 498,510 (derivative) @ $0 | EDGAR |
| 2023-09-21 | 4 | venBio Global Strategic Fund III, L.P. — 10% owner VENBIO GLOBAL STRATEGIC GP III, L.P. — 10% owner VENBIO GLOBAL STRATEGIC GP III, LTD — 10% owner Adelman Robert J — 10% owner GOODMAN COREY S — 10% owner | Conversion (C): 3,786,957 · Conversion (C): 1,123,862 · Conversion (C): 247,343 · Conversion (C): 3,786,957 (derivative) · Conversion (C): 1,123,862 (derivative) · Conversion (C): 216,127 (derivative) | EDGAR |
| 2023-09-21 | 4 | VIKING GLOBAL INVESTORS LP — 10% owner Viking Global Opportunities Parent GP LLC — 10% owner Viking Global Opportunities Drawdown GP LLC — 10% owner Viking Global Opportunities Drawdown Portfolio GP LLC — 10% owner Viking Global Opportunities Drawdown (Aggregator) LP — 10% owner HALVORSEN OLE ANDREAS — 10% owner Ott David C. — 10% owner Shabet Rose Sharon — 10% owner | Conversion (C): 864,509 · Conversion (C): 494,687 · Conversion (C): 2,609,392 · Purchase (P): 930,556 @ $18 · Conversion (C): 1,285,223 · Purchase (P): 458,333 @ $18 · +4 more | EDGAR |
| 2023-09-21 | 4 | VIKING GLOBAL INVESTORS LP — 10% owner Viking Global Opportunities Parent GP LLC — 10% owner Viking Global Opportunities GP LLC — 10% owner Viking Global Opportunities Portfolio GP LLC — 10% owner Viking Global Opportunities Illiquid Investments Sub-Master LP — 10% owner HALVORSEN OLE ANDREAS — 10% owner Ott David C. — 10% owner Shabet Rose Sharon — 10% owner | Conversion (C): 864,509 · Conversion (C): 494,687 · Conversion (C): 2,609,392 · Purchase (P): 930,556 @ $18 · Conversion (C): 1,285,223 · Purchase (P): 458,333 @ $18 · +4 more | EDGAR |
| 2023-09-19 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. — 10% owner | Conversion (C): 1,557,846 · Conversion (C): 1,557,846 (derivative) @ $0 | EDGAR |
Recent 8-K events — RayzeBio, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-02-26 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-09-19 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RYZB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs